Comparison of postoperative complications in advanced head and neck cancer patients receiving neoadjuvant chemotherapy followed by surgery versus surgery alone

被引:3
|
作者
Joshi, Poonam [1 ]
Joshi, Amit [2 ]
Prabhash, Kumar [2 ]
Noronha, Vanita [2 ]
Chaturvedi, Pankaj [1 ]
机构
[1] Tata Mem Hosp, Dept Head & Neck Surg, Bombay, Maharashtra, India
[2] Tata Mem Hosp, Dept Med Oncol, Bombay, Maharashtra, India
关键词
Complications; head and neck cancer; neoadjuvant chemotherapy; surgery;
D O I
10.4103/0971-5851.171548
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Head and neck cancer is the third most common cancer in India with 60% presenting in advanced stages. There is the emerging role of neoadjuvant chemotherapy (NACT) in the management of these advanced cancers. There is a general perception that complication rates are higher with the use of NACT. Materials and Methods: This is a retrospectively collected data of head and neck cancer patients operated at our hospital from March 2013 to September 2014. A total of 205 patients were included in the study. These patients were studied in two groups. Group 1 included 153 patients who underwent surgery alone, and Group 2 included 52 patients who received 2-3 cycles of NACT followed by surgery. Results: The mean age of the population was 51 years in the Group 1 and 45 years in Group 2. The hospital stay and readmissions in postoperative period were similar in the two groups. In this study, the complication rate was 37.9% in the surgery patients and 30.8% in the NACT patients (P = 0.424). Conclusion: The postoperative complication rates in patients who received NACT followed by surgery were not significantly different from those who underwent surgery.
引用
收藏
页码:249 / 254
页数:6
相关论文
共 50 条
  • [41] Postoperative morbidity and mortality after neoadjuvant chemotherapy versus upfront surgery for locally advanced gastric cancer: a propensity score matching analysis
    Wu, Liucheng
    Ge, Lianying
    Qin, Yuzhou
    Huang, Mingwei
    Chen, Jiansi
    Yang, Yang
    Zhong, Jianhong
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 6011 - 6018
  • [42] Role of chemotherapy in 5000 patients with head and neck cancer treated by curative surgery: A subgroup analysis of the meta-analysis of chemotherapy in head and neck cancer
    Dauzier, Etienne
    Lacas, Benjamin
    Blanchard, Pierre
    Quynh-Thu Le
    Simon, Christian
    Wolf, Gregory
    Janot, Francois
    Horiuchi, Masatoshi
    Tobias, Jeffrey S.
    Moon, James
    Simes, John
    Deshmane, Vinay
    Mazeron, Jean-Jacques
    Mehta, Samir
    Zaktonik, Branko
    Tamura, Minoru
    Moyal, Elizabeth
    Licitra, Lisa
    Fortpied, Catherine
    Haffty, Bruce G.
    Ghi, Maria Grazia
    Gregoire, Vincent
    Harris, Jonathan
    Bourhis, Jean
    Auperin, Anne
    Pignon, Jean-Pierre
    ORAL ONCOLOGY, 2019, 95 : 106 - 114
  • [43] Postoperative complications after chemoradiation for advanced head and neck cancer
    Proctor, E
    Robbins, KT
    Vieira, F
    Hanchett, C
    Sommes, G
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2004, 26 (03): : 272 - 277
  • [44] Chemotherapy-induced toxicities and treatment efficacy in advanced esophageal cancer treated with neoadjuvant chemotherapy followed by surgery
    Masaaki Motoori
    Masahiko Yano
    Takushi Yasuda
    Hiroshi Miyata
    YingFeng Peng
    Makoto Yamasaki
    Osamu Shiraishi
    Toru Masuzawa
    Koji Tanaka
    Osamu Ishikawa
    Hitoshi Shiozaki
    Yuichiro Doki
    Esophagus, 2011, 8 : 81 - 87
  • [45] Postoperative Complications in Elderly Patients Undergoing Head and Neck Surgery: Opportunities for Quality Improvement
    Cramer, John D.
    Patel, Urjeet A.
    Samant, Sandeep
    Smith, Stephanie Shintani
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2016, 154 (03) : 518 - 526
  • [46] Impact of neoadjuvant chemotherapy with PELF-protocoll versus surgery alone in the treatment of advanced gastric carcinoma
    Catharina Ruf
    Oliver Thomusch
    Matthias Goos
    Frank Makowiec
    Gerald Illerhaus
    Guenther Ruf
    BMC Surgery, 14
  • [47] Impact of neoadjuvant chemotherapy with PELF-protocoll versus surgery alone in the treatment of advanced gastric carcinoma
    Ruf, Catharina
    Thomusch, Oliver
    Goos, Matthias
    Makowiec, Frank
    Illerhaus, Gerald
    Ruf, Guenther
    BMC SURGERY, 2014, 14
  • [48] Does neoadjuvant chemotherapy plus cytoreductive surgery improve survival rates in patients with advanced epithelial ovarian cancer compared with cytoreductive surgery alone?
    Solmaz, Ulas
    Mat, Emre
    Dereli, Murat Levent
    Turan, Volkan
    Peker, Nuri
    Tosun, Gokhan
    Dogan, Askin
    Adiyeke, Mehmet
    Ozdemir, Aykut
    Gungorduk, Kemal
    Sanci, Muzaffer
    Yildirim, Yusuf
    JOURNAL OF BUON, 2015, 20 (02): : 580 - 587
  • [49] Does neoadjuvant chemotherapy plus cytoreductive surgery improve survival rates in patients with advanced epithelial ovarian cancer compared with cytoreductive surgery alone?
    Solmaz, Ulas
    Mat, Emre
    Dereli, Murat Levent
    Turan, Volkan
    Peker, Nuri
    Tosun, Gokhan
    Dogan, Askin
    Adiyeke, Mehmet
    Ozdemir, Aykut
    Gungorduk, Kemal
    Sanci, Muzaffer
    Yildirim, Yusuf
    JOURNAL OF BUON, 2015, 20 (03): : 847 - 854
  • [50] A comparison of chemotherapy plus surgery with surgery alone for localized esophageal cancer
    Rades, Dirk
    Schild, Steven E.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (04): : 190 - 191